Posts

UK launches national dementia registry to speed up search for treatments

on

The Golden Triangle and the gaps: Rethinking UK biotech – recent industry dialogue and policy context

on

Laverock Therapeutics Awarded Over £2.2M in Innovation Grants for AI‑Powered Platform and Non‑Oncology Expansion

on

Recent Biotech News: Gene Therapy Advances, Takeda Phase Success, and UK Cancer Funding

on

No Recent NICE Cardio Approval for Wegovy

on

Dr Melanie Ivarsson Appointed CEO of Health Data Research Service

on

UK Agrees to Increase Drug Spending by 25% to Avoid US Pharma Tariffs

on

Nxera Pharma to Cut 15% of Workforce in Japan and UK as Part of Restructuring Plan

on

SheMed Secures Funding for UK Expansion

on

UK Proposes Raising Payment Scheme for Branded Medicines to Nearly 25% Amid Industry Pushback

on

Barinthus Biotherapeutics Announces Reverse Merger with Clywedog Therapeutics to Form New Metabolic Disease-Focused Company

on

AstraZeneca Plans Direct US Stock Listing While Maintaining UK Headquarters

on

Bristol Myers Squibb to Launch Schizophrenia Drug Cobenfy in UK at US Price

on

A Concerning Pattern: Pharma Mulls UK Divestments as Government Action Lags in Life Sciences

on

AstraZeneca Pauses £200M Expansion in UK Amid Pharma Uncertainty

on

Eli Lilly Pauses UK Biotech Incubator Plans Amid Concerns Over NHS Drug Pricing

on

Merck Moves All R&D Operations Out of UK, Citing Unfavorable Environment

on

UK Pharma Trade Group Calls for Overhaul of Government’s Life Sciences Investment Evaluation and Medicines Pricing Schemes

on

Stockpiling Frenzy Prompts Lilly to Suspend UK Mounjaro Supply

on

UK Drugmakers and Government at Impasse Over New Medicine Rebate Scheme

on